2453 — Concord Healthcare Co Cashflow Statement
0.000.00%
- HK$4.63bn
- HK$8.04bn
- CNY388.31m
Annual cashflow statement for Concord Healthcare Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 50.6 | 152 | -94 | 509 | -186 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 50.6 | 151 | -93.6 | 509 | -186 |
Capital Expenditures | -769 | -523 | -84.9 | -184 | -325 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -83 | -422 | -15.4 | -305 | -343 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -852 | -945 | -100 | -489 | -668 |
Financing Cash Flow Items | 464 | 283 | 40.1 | -372 | -201 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1,166 | 505 | 184 | -106 | 1,018 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 365 | -289 | -9.59 | -85.9 | 164 |